Core Laboratories (Core Laboratories) Total Stockholders Equity : $195.4 Mil (As of Mar. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories Total Stockholders Equity?

Core Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $195.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Core Laboratories's Book Value per Share for the quarter that ended in Mar. 2023 was $4.19. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Core Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2023 was 1.20.

Core Laboratories Total Stockholders Equity Historical Data

The historical data trend for Core Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Total Stockholders Equity Chart

Core Laboratories Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

156.76

177.87

71.51

156.45

184.26

Core Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Stockholders Equity	Get a 7-Day Free Trial															161.79	169.14	178.54	184.26	195.39

Core Laboratories (NYSE:CLB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Core Laboratories's Book Value per Share for the quarter that ended in Mar. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(195.386	-	0)	/	46.634
	=	4.19

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Core Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.073	+	224.233)	/	195.386
	=	1.20

Core Laboratories Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Core Laboratories (Core Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6316 Windfern Road, Houston, TX, USA, 77040

Website

https://www.corelab.com

Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Executives

Katherine Murray	director	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli	officer: SVP, Gen Counsel & Secretary	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng	director	C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler	officer: SVP	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith	director	P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique	director	P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland	director	DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno	officer: President	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig	officer: VP, Counsel & Secretary	6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett	director	853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels	officer: CAO & Treasurer	6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen	director	68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes	director	6316 WINDFERN ROAD, HOUSTON TX 77040